
Opinion|Videos|January 8, 2025
Safety Considerations When Initiating Treatment for PBC
Panelists discuss how safety considerations for primary biliary cholangitis (PBC) treatment include monitoring liver function tests, managing pruritus and fatigue, assessing drug interactions, and evaluating individual patient factors like pregnancy status and comorbidities, which all influence the choice between ursodeoxycholic acid and second-line therapies.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What are the primary safety considerations when initiating treatment for primary biliary cholangitis, and how do these considerations influence initial therapy selection?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FAQ: Guidance for Pharmacists, SSRIs Under Scrutiny and Political Debate
2
What Pharmacists Should Know About High-Dose Semaglutide’s Safety Profile
3
Ensitrelvir Demonstrates Significant COVID-19 Post-Exposure Prophylaxis Efficacy in Phase 3 Trial
4
How Advanced Technology Is Reshaping Medication Safety and Pharmacy Practice
5


































































































































